This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: University of Kansas, Hylapharm, LLC. Active years: 2022-2025.
Company Filing History:
4 out of 571 
2 out of 2 Years Active: 2022-2025
Title: Jordan Hunt: Innovator in Bioenergetics and Cancer Treatment
Introduction
Jordan Hunt is a notable inventor based in Lawrence, KS (US), recognized for his contributions to the fields of bioenergetics and cancer treatment. With a total of 4 patents, he has made significant strides in developing innovative compounds and methods that address critical health issues.
Latest Patents
Hunt's latest patents include "Imidazoquinoline compounds and prodrugs thereof," which focuses on TLR7 and TLR8 agonist compounds. This technology is aimed at treating cancers and enhancing vaccine efficacy. Another significant patent is "Bioenergetically active esters for health and disease," which provides compounds and methods related to bioenergetic metabolism. These innovations are designed to promote cellular respiration and glycolytic flux, potentially treating mitochondrial disorders and neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis.
Career Highlights
Throughout his career, Jordan Hunt has worked with esteemed organizations, including the University of Kansas and Hylapharm, LLC. His work in these institutions has allowed him to collaborate with other experts in the field, further enhancing his research and development efforts.
Collaborations
Some of Hunt's notable coworkers include Laird Forrest and Ryan Moulder. Their collaborative efforts have contributed to the advancement of innovative solutions in health and disease management.
Conclusion
Jordan Hunt's work exemplifies the impact of innovation in addressing complex health challenges. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements.